Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations GlobeNewswire May 28, 2025 VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company“) announces that in accordance with the terms of an indenture entered into between the Company and […]

(NASDAQ:CGC), NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Canopy Growth Corporation (NASDAQ: CGC) between May 30, 2024 and February 6, 2025, both dates inclusive (the “Class Period”), of the important June 3, 2025 lead plaintiff deadline. SO WHAT: If

CGC DEADLINE: ROSEN, HIGHLY REGARDED INVESTOR RIGHTS COUNSEL, Encourages Canopy Growth Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action – CGC GlobeNewswire May 28, 2025 NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm,

(NasdaqGM:NPCE), NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of NeuroPace, Inc. (“NeuroPace” or the “Company”) (NASDAQ: NPCE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether NeuroPace and certain of its officers and/or directors have engaged

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. – NPCE GlobeNewswire May 28, 2025 NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of NeuroPace, Inc. (“NeuroPace” or the “Company”) (NASDAQ: NPCE). Such investors are advised to contact Danielle Peyton at

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your Everus Construction Group, Inc. (NYSE:ECG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/everus-construction-group-inc-lawsuit-submission-form?prid=150623&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

LONDON, May 28, 2025 (GLOBE NEWSWIRE) — CXOsync UK, a long-standing organiser of executive-level events, has unveiled its 2025 roadmap, reaffirming its commitment to delivering closed-door gatherings across the UK, Europe, the Middle East, and the wider EMEA region. Known for crafting tailored experiences for senior leaders in IT, Finance, HR, and Marketing, the company

CXOsync UK Unveils 2025 Executive Events Roadmap Across EMEA GlobeNewswire May 28, 2025 LONDON, May 28, 2025 (GLOBE NEWSWIRE) — CXOsync UK, a long-standing organiser of executive-level events, has unveiled its 2025 roadmap, reaffirming its commitment to delivering closed-door gatherings across the UK, Europe, the Middle East, and the wider EMEA region. Known for crafting

(NasdaqGM:RCKT), NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Rocket and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. – RCKT GlobeNewswire May 28, 2025 NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle